Search

everythinglearnresearchcommunity

for

Search:↓

Exosome therapy successfully regrew and restored natural hair color in a man with stress-related hair loss.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Tamoxifen caused hair loss in a 52-year-old woman.

Sugar molecule helps hair growth, less in balding, returns with treatment.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Combining scalp cooling with a special lotion helps prevent severe hair loss in breast cancer patients undergoing chemotherapy.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Wnt10b overexpression can regenerate hair follicles, possibly helping treat hair loss and alopecia.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.